长非编码RNA MALAT1 调节状细胞疾病相关的肺高血压中的HMOX1
Viranuj Sueblinvong1, Sarah S Chang1,2, Jing Ma1,2
1Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Cells
|January 28, 2026
概括
这项研究表明,长非编码RNA MALAT1 通过调节血红氧酶-1 (HMOX1) 的上升来保护状细胞疾病 (SCD) 中的肺高血压,提供了潜在的治疗标.
科学领域:
- 血管生物学 血管生物学
- 基因组学就是基因组学.
- 血液学 血液学 血液学
背景情况:
- 肺高血压 (PH) 是状细胞疾病 (SCD) 的严重并发症.
- 内皮功能障碍,由血液溶解期间的血红素释放引发,有助于SCD中的PH.
- 长非编码RNAs (lncRNAs) 与内皮功能障碍和PH病原发生有关.
研究的目的:
- 研究lncRNA-血氧酶-1 (HMOX1) 轴在SCD相关PH中的调节作用.
- 为了确定MALAT1在内皮平衡中的功能和SCD模型中的PH.
主要方法:
- 在状细胞 (SS) 小鼠和对照小鼠 (AA) 的肺部中 lncRNA表达概况.
- 对差异表达的 lncRNAs 的定量PCR验证.
- 在体外研究中使用经过半膜治疗的人类肺动脉内皮细胞 (HPAEC).
- 在体内研究涉及在SS小鼠中腺病毒MALAT1过度表达.
主要成果:
- 马拉特1在SS小鼠肺部和接受半膜治疗的HPAEC中显著上调.
- MALAT1 枯竭使内皮功能障碍标志物 (ET-1,VCAM1) 恶化,而过度表达则改善了它们.
- 在SS小鼠中,MALAT1过度表达减弱了PH,右心室缩和血管重塑.
- 观察到MALAT1诱导HMOX1表达和活性,减轻内皮功能障碍.
结论:
- 在SCD中,MALAT1充当对内皮功能障碍,血管重塑和PH的保护性调节剂.
- MALAT1-HMOX1轴在与SCD相关的PH病变发生过程中起着至关重要的作用.
- MALAT1调制代表了SCD相关PH的潜在治疗策略.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
01:30Pulmonary Hypertension: Classification and Pathogenesis
632
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
632
01:18Hypertension and Regulation of Blood Pressure
4.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.1K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
595
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
595
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
464
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464